1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
MariMed Inc.

MariMed Inc.

MRMD
MariMed Inc.US flagOther OTC
0.07
USD
+0.00
- -
27.55MMarket Cap

Total Valuation

MariMed Inc. carries a market capitalization of 27.55M, placing it among publicly traded companies globally. Its enterprise value stands at 108.54M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap27.55M
Enterprise Value108.54M

Share Statistics

MariMed Inc. currently has 398.91M shares outstanding.

Shares Outstanding398.91M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.17, and the price-to-book ratio stands at -0.21.

PE RatioN/A
PS Ratio0.17
PB Ratio-0.21
P/TBV Ratio4.44
P/FCF Ratio2.88
P/OCF Ratio3.69

Enterprise Valuation

On an enterprise value basis, MariMed Inc. trades at an EV/EBITDA multiple of 9.98 and an EV/FCF ratio of 5.43. The EV/Sales ratio of 0.67 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 106.70 provides insight into valuation relative to core operating earnings.

EV / Sales0.67
EV / EBITDA9.98
EV / EBIT106.70
EV / FCF5.43

Financial Position

MariMed Inc. maintains a current ratio of 0.95, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 196.10, indicating elevated leverage, while an interest coverage ratio of 1.41 demonstrates limited ability to service its debt obligations.

Current Ratio0.95
Quick Ratio0.29
Debt / Equity196.10
Debt / EBITDA8.39
Interest Coverage1.41

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-6.17
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.69

Taxes

Income Tax3.41M
Effective Tax RateN/A

Stock Price Statistics

MariMed Inc.'s stock has declined approximately -2.12766% over the past 52 weeks. The 50-day moving average sits at 0.08, while the 200-day moving average is 0.10.

Beta (5Y)N/A
52-Week Price Change-2.12766%
50-Day Moving Average0.08
200-Day Moving Average0.10
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, MariMed Inc. generated 161.51M in revenue and converted that into -12.63M in net income, yielding earnings per share of -0.03. EBITDA reached 10.87M, while operating income came in at -847,000.00.

Revenue161.51M
Gross Profit58.17M
Operating Income-847,000.00
Pretax Income-9.20M
Net Income-12.63M
EBITDA10.87M
EBIT-847,000.00
Earnings Per Share (EPS)-0.03

Balance Sheet

MariMed Inc. holds 7.94M in cash and equivalents against 91.21M in total debt, resulting in a net debt position of 71.39M. Total book value stands at -131.32M, with working capital of -2.97M providing operational flexibility.

Cash & Cash Equivalents7.94M
Total Debt91.21M
Net Debt71.39M
Equity (Book Value)-131.32M
Book Value Per Share-0.33
Working Capital-2.97M

Cash Flow

MariMed Inc. produced 7.35M in operating cash flow over the past twelve months. After subtracting -2.06M in capital expenditures, free cash flow totaled 5.29M - equivalent to 0.01 per share.

Operating Cash Flow7.35M
Capital Expenditures-2.06M
Free Cash Flow5.29M
FCF Per Share0.01

Margins

MariMed Inc. operates with a gross margin of 36.02, reflecting its pricing power and cost economics. The operating margin of -0.52 and net profit margin of -7.82 provide insight into operational efficiency.

Gross Margin36.02
Operating Margin-0.52
Pretax Margin-5.70
Profit Margin-7.82
EBITDA Margin6.73

Dividends & Yields

The company's payout ratio of -1.02 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.00
Dividend YieldN/A
Payout Ratio-1.02
Shareholder Yield16.93
FCF Yield34.67

Scores

MariMed Inc. posts an Altman Z-Score of -0.08, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-0.08